Peptide Blends · Exact presentation
CJC-1295 + GHRP-2 · 10 mg Blend
CJC-1295 + GHRP-2 · 10 mg Blend is a declared multi-component single-vial blend. Evidence for each component does not automatically establish the performance of the combination.
Educational research information for this exact variation. It is not medical advice, a prescription, or proof of regulatory approval.
CJC-1295 + GHRP-2 (10 mg Blend) Dosage Protocol
The source chart summarizes “150 mcg–300 mcg” at “Daily” frequency as educational information. PeptidosRD does not convert it into a clinical recommendation; any protocol must be checked against primary studies, applicable labeling, and qualified oversight.
Dosing & Reconstitution Guide
For a 10 mg presentation, the reference concentration of 3.33 mg/mL mathematically corresponds to 3.003 mL final volume. This is concentration math, not a universal preparation instruction; the lot CoA and documentation control. 3.33 mg/mL. On a U-100 syringe, 1 unit equals 0.01 mL; the amount per unit would be 0.0333 mg at this concentration.
Standard / Gradual Approach (3 mL = ~3.33 mg/mL)
The source chart summarizes “150 mcg–300 mcg” at “Daily” frequency as educational information. PeptidosRD does not convert it into a clinical recommendation; any protocol must be checked against primary studies, applicable labeling, and qualified oversight.
Standard / Gradual Approach (3 mL = ~3.33 mg/mL)
| Week | Daily Dose (mcg) | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–2 | 150 mcg (0.15 mg) | 4.5 units (0.045 mL) |
| Weeks 3–12 | 300 mcg (0.30 mg) | 9 units (0.09 mL) |
Reconstitution Steps
For a 10 mg presentation, the reference concentration of 3.33 mg/mL mathematically corresponds to 3.003 mL final volume. This is concentration math, not a universal preparation instruction; the lot CoA and documentation control. 3.33 mg/mL. On a U-100 syringe, 1 unit equals 0.01 mL; the amount per unit would be 0.0333 mg at this concentration.
Advanced / Twice-Daily Approach (3 mL = ~3.33 mg/mL)
The source chart summarizes “150 mcg–300 mcg” at “Daily” frequency as educational information. PeptidosRD does not convert it into a clinical recommendation; any protocol must be checked against primary studies, applicable labeling, and qualified oversight.
Advanced / Twice-Daily Approach (3 mL = ~3.33 mg/mL)
| Week | Dose per Injection (mcg) | Units (per injection) (mL) | Total Daily (mcg) |
|---|---|---|---|
| Weeks 1–2 | 100 mcg (0.10 mg) | 3 units (0.03 mL) | 200 mcg |
| Weeks 3–12 | 150 mcg (0.15 mg) | 4.5 units (0.045 mL) | 300 mcg |
Storage Instructions
Proper storage preserves peptide quality.
Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; stable for 1+ year.[5]
Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 3–4 weeks and avoid freeze–thaw.[6]
Allow vials to reach room temperature before opening to reduce condensation uptake.
How This Works
The proposed mechanism depends on the molecular identity and receptor systems described in the literature. A mechanism alone does not establish clinical efficacy.
Potential Benefits & Side Effects
Identity, purity, sterility, stability, and equivalence to studied products cannot be assumed. Adverse effects and interactions may be incompletely characterized.
Source trail
Scientific references and source discovery
- PeptideDosages — exact CJC-1295 + GHRP-2 · 10 mg Blend entrysecondary-structure
- PubMed — literature search for CJC-1295 + GHRP-2primary-discovery
- ClinicalTrials.gov — study search for CJC-1295 + GHRP-2trial-registry
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference
- View Sourcesource-reference